Literature DB >> 29381619

Intralesional Bleomycin Injection for Propranolol-Resistant Hemangiomas.

Lei Chang1, Hui Chen, Xi Yang, Yunbo Jin, Gang Ma, Xiaoxi Lin.   

Abstract

Propranolol has been the first-line treatment for alarming hemangiomas. However, some hemangiomas are propranolol-resistant. The authors reported 1 propranolol-resistant hemangioma which was treated with intralesional bleomycin injections. Sixteen months after 3 injections, the lesion still remained stable. Its potential mechanism was clarified by ultrasonic monitoring. Intralesional bleomycin injection can be considered an ideal option in treating propranolol-resistant hemangiomas.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29381619     DOI: 10.1097/SCS.0000000000004152

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Intramuscular hemangioma of the pretarsal orbicularis oculi muscle in an adult treated with intralesional bleomycin injections.

Authors:  Halla A AlAbdulhadi; Mohammed A AlFayyadh; Khadeejah S AlBadri
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-26

2.  Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomas.

Authors:  Hongrang Chen; Yongsheng Li
Journal:  Hum Genomics       Date:  2022-09-27       Impact factor: 6.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.